Top Stories
Top Stories
Market Insider

Early movers: INTC, LOCO, ARO, ULTA, PFE, TM & more

Check out which companies are making headlines before the bell:

Intel—Cannacord upgraded the chipmaker's stock to "buy" from "hold," saying Intel's fundamentals have improved. It also noted the 15 percent year-to-date drop, including Thursday's decline following a cut by Intel for its revenue forecast.

The Buckle—The apparel and accessories retailer earned $1.25 per share for its latest quarter, beating estimates by 1 cent. Revenue was also above estimates as comparable store sales rose 1.1 percent from a year earlier.

Toyota—According to an IOC statement, the automaker has signed an agreement to be a leading sponsor of the Olympic Games until 2024.

El Pollo Loco—The restaurant chain reported adjusted quarterly profit of 14 cents per share, 2 cents above estimates. El Pollo Loco's revenue also beat forecasts, and its forecasts for 2015 are largely above estimates. The company is projecting same-restaurant sales to increase by three to five percent this year.

Aeropostale—The apparel retailer earned an adjusted 1 cent per share for its latest quarter, compared to analyst forecasts of a 3 cents per share loss. Revenue came in above forecasts, but Aeropostale's current-quarter forecast is for a wider-than-expected loss due to weak mall traffic.

Stocks make sharp turn ahead of Fed meeting

Ulta Salon—The beauty supplies retailer beat estimates by 8 cents with quarterly profit of $1.35 per share, with revenue slightly above forecasts. Comparable store sales for Ulta were up 11.1 percent, well above estimates of 7.5 percent.

Fiat Chrysler—CEO Sergio Marchionne told Bloomberg News a business combination with General Motors or Ford Motor is "technically feasible." Marchionne has said many times in the past that only the largest automakers will be able to survive long term.

Google—Google is not planning to compete aggressively with soon-to-be-public GoDaddy in the internet domain space, according to a report in today's New York Post.

Pfizer—Pfizer's pain drug Lyrica did not meet goals in a study that examined its effectiveness in treating adolescents with fibromyalgia.

Herbalife—Dow Jones reports that prosecutors are interviewing people tied to investor Bill Ackman in a case involving potential manipulation of Herbalife's stock. Ackman has had a long-standing short position in Herbalife, saying the nutritional supplements maker is a pyramid scheme. He told CNBC he has not heard from the FBI or the Justice Department, and that he's happy to answer any questions they may have for him.

Zumiez—The retailer said it would earn 8 to 10 cents per share for the current quarter, below analyst estimates of 14 cents. The seller of teen apparel and sports equipment also sees same-store sales up three to four percent this quarter.

Questions? Comments? Email us at